OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (OHCM)
Clinical trials for OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (OHCM) explained in plain language.
Never miss a new study
Get alerted when new OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (OHCM) trials appear
Sign up with your email to follow new studies for OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (OHCM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New heart drug trial aims to ease strain for patients with thickened heart muscle
Disease control Recruiting nowThis study is testing whether a medication called ademetionine can help people with obstructive hypertrophic cardiomyopathy (oHCM), a condition where the heart muscle thickens and makes it harder to pump blood. About 44 participants will be randomly assigned to receive either the…
Matched conditions: OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (OHCM)
Phase: PHASE2 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New heart drug under watch in japan
Disease control Recruiting nowThis study is monitoring the real-world safety and effectiveness of the drug mavacamten in Japanese patients with obstructive hypertrophic cardiomyopathy (oHCM), a condition where the heart muscle thickens and obstructs blood flow. It will enroll about 200 patients who are prescr…
Matched conditions: OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (OHCM)
Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC